The Future of Precision Medicine in the Cure of Alzheimer’s Disease

Dermatologist-level classification of skin cancer with deep neural networks

Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362 · see citing works

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

The UK Biobank resource with deep phenotyping and genomic data

Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876 · see citing works

Glutamate neurotoxicity and diseases of the nervous system

Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,152 · see citing works

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works

A New Initiative on Precision Medicine

Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202 · see citing works

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · see citing works

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · see citing works

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · see citing works

Mechanisms underlying inflammation in neurodegeneration

Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · see citing works

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321 · see citing works

Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer

Ehteshami Bejnordi, B., Veta, M., Johannes van Diest, P., van Ginneken, B., Karssemeijer, N., Litjens, G., van der Laak, J. A. W. M., and the CAMELYON16 Consortium, Hermsen, M., Manson, Q. F., et al. (2017) · JAMA · doi:10.1001/jama.2017.14585 · Cited by 3,293 · see citing works

Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease

Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · see citing works

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · see citing works

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · see citing works

Alzheimer's disease

Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336 · see citing works

The practical implementation of artificial intelligence technologies in medicine

He, J., Baxter, S. L., Xu, J., Xu, J., Zhou, X., & Zhang, K. (2019) · Nature Medicine · doi:10.1038/s41591-018-0307-0 · Cited by 2,246 · see citing works

End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography

Ardila, D., Kiraly, A. P., Bharadwaj, S., Choi, B., Reicher, J. J., Peng, L., Tse, D., Etemadi, M., Ye, W., Corrado, G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0447-x · Cited by 2,167 · see citing works

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065 · see citing works

Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning

Poplin, R., Varadarajan, A. V., Blumer, K., Liu, Y., McConnell, M. V., Corrado, G. S., Peng, L., & Webster, D. R. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0195-0 · Cited by 1,865 · see citing works

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · see citing works

Innate immune activation in neurodegenerative disease

Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · see citing works

ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors

Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,426 · see citing works

Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains

Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383 · see citing works

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363 · see citing works

Personal omics profiling reveals dynamic molecular and medical phenotypes

Chen, R., Mias, G. I., Li-Pook-Than, J., Jiang, L., Lam, H. Y. K., Chen, R., Miriami, E., Karczewski, K. J., Hariharan, M., Dewey, F. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.009 · Cited by 1,291 · see citing works

A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme Activity

Weisberg, I. S., Tran, P. V., Christensen, B., Sibani, S., & Rozen, R. R. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2714 · Cited by 1,287 · see citing works

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196 · see citing works

Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine

Ahmed, Z., Mohamed, K., Zeeshan, S., & Dong, X. (2020) · Database · doi:10.1093/database/baaa010 · Cited by 1,035 · see citing works

Tau positron emission tomographic imaging in aging and early <scp>A</scp> lzheimer disease

Johnson, K. A., Schultz, A., Betensky, R. A., Becker, J. A., Sepulcre, J., Rentz, D., Mormino, E., Chhatwal, J., Amariglio, R., Papp, K., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24546 · Cited by 986 · see citing works

Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature

Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975 · see citing works

Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria

Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972 · see citing works

A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease

Panza, F., Lozupone, M., Logroscino, G., & Imbimbo, B. P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0116-6 · Cited by 965 · see citing works

Genetic Linkage Evidence for a Familial Alzheimer's Disease Locus on Chromosome 14

Schellenberg, G. D., Bird, T. D., Wijsman, E. M., Orr, H. T., Anderson, L., Nemens, E. J., White, J. A., Bonnycastle, L. L., Weber, J. L., Alonso, M. E., et al. (1992) · Science · doi:10.1126/science.1411576 · Cited by 941 · see citing works

The genetic landscape of Alzheimer disease: clinical implications and perspectives

Van Cauwenberghe, C., Van Broeckhoven, C., & Sleegers, K. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.117 · Cited by 863 · see citing works

Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial

Smith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012244 · Cited by 813 · cited 2× · see citing works

Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum

Campion, D., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., Thomas-Anterion, C., Michon, A., Martin, C., Charbonnier, F., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302553 · Cited by 785 · see citing works

Precision Medicine: From Science To Value

Ginsburg, G. S., & Phillips, K. A. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1624 · Cited by 767 · see citing works

A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction

Yala, A., Lehman, C., Schuster, T., Portnoi, T., & Barzilay, R. (2019) · Radiology · doi:10.1148/radiol.2019182716 · Cited by 758 · see citing works

A comprehensive review of amyotrophic lateral sclerosis

Zarei, S., Carr, K., Reiley, L. E., Diaz, K., Guerra, O., Altamirano, P., Pagani, W., Lodin, D., Orozco, G., & Chinea, A. R. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.169561 · Cited by 737 · see citing works

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease

Brier, M. R., Gordon, B., Friedrichsen, K., McCarthy, J., Stern, A., Christensen, J., Owen, C., Aldea, P., Su, Y., Hassenstab, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2362 · Cited by 734 · see citing works

The β-Secretase BACE1 in Alzheimer’s Disease

Hampel, H., Vassar, R., De Strooper, B., Hardy, J., Willem, M., Singh, N., Zhou, J., Yan, R., Vanmechelen, E., De Vos, A., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.001 · Cited by 694 · see citing works

In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand ¹⁸ F-AV-45 (Flobetapir F 18)

Wong, D. F., Rosenberg, P. B., Zhou, Y., Kumar, A., Raymont, V., Ravert, H. T., Dannals, R. F., Nandi, A., Brašić, J. R., Ye, W., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069088 · Cited by 684 · see citing works

Machine learning for integrating data in biology and medicine: principles, practice, and opportunities

Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675 · see citing works

Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia

Buchhave, P. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.155 · Cited by 664 · see citing works

Etiology and pathogenesis of Parkinson's disease

Schapira, A. H. V., & Jenner, P. G. (2011) · Movement Disorders · doi:10.1002/mds.23732 · Cited by 659 · see citing works

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Hampel, H. J., Frank, R., Broich, K., Teipel, S. J., Katz, R. G., Hardy, J., Herholz, K., Bokde, A. L. W., Jessen, F., Hoessler, Y. C., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3115 · Cited by 630 · see citing works

Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET

La Joie, R., Visani, A. V., Baker, S. L., Brown, J. A., Bourakova, V., Cha, J., Chaudhary, K., Edwards, L., Iaccarino, L., Janabi, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5732 · Cited by 612 · see citing works

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer’s disease

Jones, L., Holmans, P. A., Hamshere, M. L., Harold, D., Moskvina, V., Ivanov, D., Pocklington, A., Abraham, R., Hollingworth, P., Sims, R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013950 · Cited by 606 · see citing works

Enabling Technologies for Personalized and Precision Medicine

Ho, D., Quake, S. R., McCabe, E. R. B., Chng, W. J., Chow, E. K., Ding, X., Gelb, B. D., Ginsburg, G. S., Hassenstab, J., Ho, C.-M., et al. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.021 · Cited by 517 · see citing works

Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment

Douaud, G., Refsum, H., de Jager, C. A., Jacoby, R. J., Nichols, T. E., Smith, S. M., & Smith, A. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301816110 · Cited by 515 · see citing works

A Longitudinal Big Data Approach for Precision Health

Schüssler-Fiorenza Rose, S. M., Contrepois, K., Moneghetti, K. J., Zhou, W., Mishra, T., Mataraso, S., Dagan-Rosenfeld, O., Ganz, A. B., Dunn, J., Hornburg, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0414-6 · Cited by 494 · see citing works

Presenilins and -Secretase: Structure, Function, and Role in Alzheimer DiseasePreprint

Strooper, B. D., Iwatsubo, T., & Wolfe, M. S. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006304 · Cited by 465 · see citing works

The Public Health Impact of Alzheimer's Disease, 2000–2050: Potential Implication of Treatment Advances

Sloane, P. D., Zimmerman, S. I., Suchindran, C., Reed, P. S., Wang, L., Boustani, M. A., & Sudha, S. (2002) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.23.100901.140525 · Cited by 461 · see citing works

Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447 · see citing works

A wellness study of 108 individuals using personal, dense, dynamic data clouds

Price, N. D., Magis, A. T., Earls, J. C., Glusman, G., Levy, R., Lausted, C., McDonald, D. T., Kusebauch, U., Moss, C. L., Zhou, Y., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3870 · Cited by 427 · see citing works

Regional profiles of the candidate tau PET ligand ¹⁸ F-AV-1451 recapitulate key features of Braak histopathological stages

Schwarz, A. J., Yu, P., Miller, B. B., Shcherbinin, S., Dickson, J., Navitsky, M., Joshi, A. D., Devous, M. D., & Mintun, M. S. (2016) · Brain · doi:10.1093/brain/aww023 · Cited by 425 · see citing works

β-Amyloid burden in healthy aging: Regional distribution and cognitive consequences

Rodrigue, K. M., Kennedy, K. M., Devous, M. D., Rieck, J. R., Hebrank, A. C., Diaz-Arrastia, R., Mathews, D., & Park, D. C. (2012) · Neurology · doi:10.1212/wnl.0b013e318245d295 · Cited by 419 · see citing works

A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment

on behalf of the Rofecoxib Protocol 078 study group, Thal, L. J., Ferris, S. H., Kirby, L., Block, G. A., Lines, C. R., Yuen, E., Assaid, C., Nessly, M. L., Norman, B. A., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300690 · Cited by 402 · see citing works

Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile

Winston, C. N., Goetzl, E. J., Akers, J. C., Carter, B. S., Rockenstein, E. M., Galasko, D. R., Masliah, E., & Rissman, R. A. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.04.001 · Cited by 379 · see citing works

Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease

Decourt, B., Lahiri, D. K., & Sabbagh, M. N. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160930110551 · Cited by 373 · see citing works

Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease

Fleisher, A. S. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.150 · Cited by 364 · see citing works

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease

Hampel, H., Caraci, F., Cuello, A. C., Caruso, G., Nisticò, R., Corbo, M., Baldacci, F., Toschi, N., Garaci, F., Chiesa, P. A., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00456 · Cited by 360 · see citing works

The need for a system view to regulate artificial intelligence/machine learning-based software as medical device

Gerke, S., Babic, B., Evgeniou, T., & Cohen, I. G. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0262-2 · Cited by 359 · see citing works

Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress

Bisht, K., Sharma, K. P., & Tremblay, M. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.05.003 · Cited by 351 · see citing works

Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia

Ewers, M., Sperling, R. A., Klunk, W. E., Weiner, M. W., & Hampel, H. J. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.005 · Cited by 345 · see citing works

Amyloid-β(1–42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease

Mulder, C., Verwey, N. A., van der Flier, W. M., Bouwman, F. H., Kok, A., van Elk, E. J., Scheltens, P., & Blankenstein, M. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.130518 · Cited by 332 · see citing works

Mapping of a gene predisposing to early–onset Alzheimer's disease to chromosome 14q24.3

Broeckhoven, C. V., Backhovens, H., Cruts, M., Winter, G. D., Bruyland, M., Cras, P. P., & Martin, J. (1992) · Nature Genetics · doi:10.1038/ng1292-335 · Cited by 325 · see citing works

The exposome in practice: Design of the EXPOsOMICS project

Vineis, P., Chadeau‐Hyam, M., Gmuender, H., Gulliver, J., Herceg, Z., Kleinjans, J. C. S., Kogevinas, M., Kyrtopoulos, S. Α., Nieuwenhuijsen, M. J., Phillips, D. H., et al. (2016) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2016.08.001 · Cited by 325 · see citing works

The genetics and neuropathology of Parkinson’s disease

Houlden, H., & Singleton, A. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1013-5 · Cited by 320 · see citing works

The future of blood‐based biomarkers for Alzheimer's disease

Henriksen, K., O’Bryant, S. E., Hampel, H. J., Trojanowski, J. Q., Montine, T. J., Jeromin, A., Blennow, K., Lönneborg, A., Wyss‐Coray, T., Soares, H. D., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.013 · Cited by 312 · see citing works

Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis

Zhao, W., Beers, D. R., & Appel, S. H. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9489-x · Cited by 298 · see citing works

Inflammatory mechanisms in Alzheimer's disease

Eikelenboom, P., Zhan, S., van Gool, W. A., & Allsop, D. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90057-4 · Cited by 291 · see citing works

Guidelines for the standardization of preanalytic variables for blood‐based biomarker studies in Alzheimer's disease research

O’Bryant, S. E., Gupta, V. B., Henriksen, K., Edwards, M., Jeromin, A., Lista, S., Bazenet, C. E., Soares, H. D., Lovestone, S., Hampel, H. J., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.08.099 · Cited by 290 · see citing works

Glial activation and inflammation along the Alzheimer’s disease continuum

Nordengen, K., Kirsebom, B.-E., Henjum, K., Selnes, P., Gísladóttir, B., Wettergreen, M., Torsetnes, S. B., Grøntvedt, G. R., Waterloo, K. K., Aarsland, D., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1399-2 · Cited by 274 · see citing works

ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes

Higgins, C. M. J., Jung, C., & Xu, Z. (2003) · BMC Neuroscience · doi:10.1186/1471-2202-4-16 · Cited by 262 · see citing works

Mitochondrial Alterations in the Spinal Cord of Patients With Sporadic Amyotrophic Lateral Sclerosis

Sasaki, S., & Iwata, M. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31802c396b · Cited by 256 · see citing works

Precision medicine in cardiology

Antman, E. M., & Loscalzo, J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.101 · Cited by 252 · see citing works

Alzheimer’s disease phenotypes and genotypes associated with mutations in presenilin 2

Jayadev, S., Leverenz, J. B., Steinbart, E. J., Stahl, J. H., Klunk, W. E., Yu, C.-E., & Bird, T. D. (2010) · Brain · doi:10.1093/brain/awq033 · Cited by 246 · see citing works

Clinical amyloid imaging in Alzheimer's disease

Herholz, K., & Ebmeier, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70123-5 · Cited by 240 · see citing works

Assessment of the genetic variance of late-onset Alzheimer's disease

Ridge, P. G., Hoyt, K. B., Boehme, K., Mukherjee, S., Crane, P. K., Haines, J. L., Mayeux, R., Farrer, L. A., Pericak-Vance, M. A., Schellenberg, G. D., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.024 · Cited by 236 · see citing works

Protection against Alzheimer's disease with apoE ∈2

Talbot, C., Lendon, C., Craddock, N., Shears, S., Morris, J., & Goate, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92557-7 · Cited by 225 · see citing works

Interleukin-1β impairs brain derived neurotrophic factor-induced signal transduction

Tong, L., Balazs, R., Soiampornkul, R., Thangnipon, W., & Cotman, C. W. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.027 · Cited by 222 · see citing works

Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment

Lombardi, G., Crescioli, G., Cavedo, E., Lucenteforte, E., Casazza, G., Bellatorre, A.-G., Lista, C., Costantino, G., Frisoni, G., Virgili, G., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009628.pub2 · Cited by 214 · see citing works

Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial

Solomon, A., Turunen, H., Ngandu, T., Peltonen, M., Levälahti, E., Helisalmi, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4365 · Cited by 213 · see citing works

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage

Poil, S., de Haan, W., van der Flier, W. M., Mansvelder, H. D., Scheltens, P., & Linkenkaer‐Hansen, K. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00058 · Cited by 209 · see citing works

Intramembrane Proteolysis by γ-Secretase

Steiner, H., Fluhrer, R., & Haass, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800010200 · Cited by 207 · see citing works

Homocysteine and Cognitive Decline in Healthy Elderly

McCaddon, A., Hudson, P. R., Davies, G. K., Hughes, A., Williams, J. H. H., & Wilkinson, C. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051275 · Cited by 206 · see citing works

Low vitamin B-12 status and risk of cognitive decline in older adults

Clarke, R., Birks, J., Nexo, E., Ueland, P. M., Schneede, J., Scott, J., Molloy, A., & Evans, J. G. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1384 · Cited by 203 · see citing works

Transethnic genome‐wide scan identifies novel Alzheimer's disease loci

Jun, G. R., Chung, J., Mez, J., Barber, R., Beecham, G. W., Bennett, D. A., Buxbaum, J. D., Byrd, G. S., Carrasquillo, M. M., Crane, P. K., et al. (2017) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2016.12.012 · Cited by 197 · see citing works

Genetic variation and the lipid response to dietary intervention: a systematic review

Masson, L. F., McNeill, G., & Avenell, A. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1098 · Cited by 196 · see citing works

Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study

AV45-A11 Study Group, Doraiswamy, P. M., Sperling, R. A., Johnson, K., Reiman, E. M., Wong, T. Z., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., Carpenter, A., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.9 · Cited by 195 · see citing works

Relevance of Magnetic Resonance Imaging for Early Detection and Diagnosis of Alzheimer Disease

Teipel, S. J., Grothe, M. J., Lista, S., Toschi, N., Garaci, F., & Hampel, H. J. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.12.013 · Cited by 192 · see citing works

Biomarker Tests for Molecularly Targeted Therapies — The Key to Unlocking Precision Medicine

Lyman, G. H., & Moses, H. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1604033 · Cited by 166 · see citing works

Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer’s Disease

Fowler, C., Rainey-Smith, S. R., Bird, S., Bomke, J., Bourgeat, P., Brown, B. M., Burnham, S. C., Bush, A. I., Chadunow, C., Collins, S., et al. (2021) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-210005 · Cited by 164 · see citing works

Biological markers of amyloid β-related mechanisms in Alzheimer's disease

Hampel, H. J., Shen, Y., Walsh, D. M., Aisen, P. S. S., Shaw, L. M., Zetterberg, H., Trojanowski, J. Q., & Blennow, K. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.024 · Cited by 159 · see citing works

Levodopa

Agid, Y. (1998) · Neurology · doi:10.1212/wnl.50.4.858 · Cited by 157 · see citing works

Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers

Yassine, H. N., Braskie, M. N., Mack, W. J., Castor, K., Fonteh, A. N., Schneider, L. S. S., Harrington, M. G., & Chui, H. C. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4899 · Cited by 155 · see citing works

PET imaging of brain amyloid in dementia: a review

Quigley, H., Colloby, S. J., & O'Brien, J. T. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2640 · Cited by 150 · see citing works

Amyloid β-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease

Bruno, M. A., León, W., Fragoso, G., Mushynski, W. E., Almazán, G., & Cuello, A. C. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181aed9e6 · Cited by 148 · see citing works

A Precision Medicine Initiative for Alzheimer’s disease: the road ahead to biomarker-guided integrative disease modeling

Hampel, H., O’Bryant, S. E., Durrleman, S., Younesi, E., Rojkova, K., Escott-Price, V., Corvol, J.-C., Broich, K., Dubois, B., Lista, S., et al. (2017) · Climacteric · doi:10.1080/13697137.2017.1287866 · Cited by 147 · see citing works

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020

Hampel, H. J., Lista, S., Teipel, S. J., Garaci, F., Nisticò, R., Blennow, K., Zetterberg, H., Bertram, L., Duyckaerts, C. J., Bakardjian, H., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.009 · Cited by 141 · see citing works

Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study

Durrenberger, P. F., Fernando, F. S., Kashefi, S. N., Bonnert, T. P., Seilhean, D., Nait‐Oumesmar, B., Schmitt, A., Gebicke‐Haerter, P. J., Falkai, P., Grünblatt, E., et al. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1293-0 · Cited by 139 · see citing works

Development of biomarkers to chart all Alzheimer's disease stages: The royal road to cutting the therapeutic Gordian Knot

Hampel, H. J., Lista, S., & Khachaturian, Z. S. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.2116 · Cited by 138 · see citing works

Precision medicine: the foundation of future cancer therapeutics

Shin, S. H., Bode, A. M., & Dong, Z. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0016-z · Cited by 129 · see citing works

C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease

Duong, T., Nikolaeva, M. A., & Acton, P. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01359-5 · Cited by 127 · see citing works

Mitochondrial Function, Morphology, and Axonal Transport in Amyotrophic Lateral Sclerosis

Magrané, J., & Manfredi, G. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2604 · Cited by 127 · see citing works

A key role for TGF-β1 in hippocampal synaptic plasticity and memory

Caraci, F., Gulisano, W., Guida, C. A., Impellizzeri, A. A. R., Drago, F., Puzzo, D., & Palmeri, A. (2015) · Scientific Reports · doi:10.1038/srep11252 · Cited by 126 · see citing works

Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis

Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · see citing works

Cognitive Performance in Older Women Relative to ApoE-ε4 Genotype and Aerobic Fitness

ETNIER, J. L., CASELLI, R. J., REIMAN, E. M., ALEXANDER, G. E., SIBLEY, B. A., TESSIER, D., & MCLEMORE, E. C. (2007) · Medicine &amp; Science in Sports &amp; Exercise · doi:10.1249/01.mss.0000239399.85955.5e · Cited by 124 · see citing works

Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline

Grundman, M., Pontecorvo, M. J., Salloway, S., Doraiswamy, P. M., Fleisher, A., Sadowsky, C., Nair, A. K., Siderowf, A. D., Lu, M., Arora, A., et al. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318279d02a · Cited by 119 · see citing works

PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE

Hampel, H. J., O’Bryant, S. E., Castrillo, J. I., Ritchie, C. W., Rojkova, K., Broich, K., Benda, N., Nisticò, R., Frank, R., Dubois, B., et al. (2016) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2016.112 · Cited by 116 · see citing works

Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration

Chen, X., Kordich, J. K., Williams, E. T., Levine, N. D., Cole-Strauss, A., Marshall, L. L., Labrie, V., Ma, J., Lipton, J. W., & Moore, D. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814909116 · Cited by 114 · see citing works

Biomarkers in Sporadic and Familial Alzheimer’s Disease

Lista, S., O’Bryant, S. E., Blennow, K., Dubois, B., Hugon, J., Zetterberg, H., & Hampel, H. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143006 · Cited by 106 · see citing works

Precision medicine screening using whole-genome sequencing and advanced imaging to identify disease risk in adults

Perkins, B. A., Caskey, C. T., Brar, P., Dec, E., Karow, D. S., Kahn, A. M., Hou, Y. C., Shah, N., Boeldt, D., Coughlin, E., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706096114 · Cited by 104 · see citing works

Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications

Ferreira, L. K., & Busatto, G. F. (2011) · Clinics · doi:10.1590/s1807-59322011001300003 · Cited by 102 · see citing works

Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system

Hernández-Romero, M. C., Delgado-Cortés, M. J., Sarmiento, M., de Pablos, R. M., Espinosa-Oliva, A. M., Argüelles, S., Bández, M. J., Villarán, R. F., Mauriño, R., Santiago, M., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.018 · Cited by 100 · see citing works

Toward precision medicine in Alzheimer’s disease

Reitz, C. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.03.05 · Cited by 100 · see citing works

Personalized medicine in diabetes: the role of ‘omics’ and biomarkers

Pearson, E. R. (2016) · Diabetic Medicine · doi:10.1111/dme.13075 · Cited by 94 · see citing works

Biomarker discovery for Alzheimer’s disease, frontotemporal lobar degeneration, and Parkinson’s disease

Hu, W. T., Chen‐Plotkin, A. S., Arnold, S. E., Grossman, M., Clark, C. M., Shaw, L. M. J., McCluskey, L. F., Elman, L. B., Karlawish, J. H., Hurtig, H. I., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0723-9 · Cited by 90 · see citing works

Validation of a Serum Screen for Alzheimer's Disease Across Assay Platforms, Species, and Tissues

O’Bryant, S. E., Xiao, G., Zhang, F., Edwards, M., German, D. C., Yin, X., Como, T., Reisch, J., Huebinger, R. M., Graff‐Radford, N. R., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141041 · Cited by 87 · see citing works

Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkers

DeMarshall, C. A., Nagele, E. P., Sarkar, A., Acharya, N. K., Godsey, G. A., Goldwaser, E. L., Kosciuk, M. C., Thayasivam, U., Han, M. C., Belinka, B. A., et al. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.03.002 · Cited by 86 · see citing works

Alpha-synuclein dysfunction in Lewy body diseases

Tofaris, G. K., & Spillantini, M. G. (2005) · Movement Disorders · doi:10.1002/mds.20538 · Cited by 84 · see citing works

Enabling Privacy-Preserving GWASs in Heterogeneous Human Populations

Simmons, S., Şahinalp, S. C., & Berger, B. (2016) · Cell Systems · doi:10.1016/j.cels.2016.04.013 · Cited by 78 · see citing works

MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease

Guedes, J. R., Santana, I. J., Cunha, C., Duro, D., Almeida, M. R., Cardoso, A. M., de Lima, M. C. P., & Cardoso, A. L. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.11.004 · Cited by 76 · see citing works

Genotype patterns at CLU, CR1, PICALM and APOE, cognition and Mediterranean diet: the PREDIMED-NAVARRA trial

Martínez‐Lapiscina, E. H., Galbete, C., Corella, D., Toledo, E., Buil‐Cosiales, P., Salas‐Salvadó, J., Ros, E., & Martínez‐González, M. Á. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0393-7 · Cited by 69 · see citing works

Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I

Finckh, U., Alberici, A., Antoniazzi, M., Benussi, L., Fedi, V., Giannini, C., Gal, A., Nitsch, R. M., & Binetti, G. G. (2000) · Neurology · doi:10.1212/wnl.54.10.2006 · Cited by 67 · see citing works

Mitochondrial Involvement in Amyotrophic Lateral Sclerosis: Trigger or Target?

Bacman, S. R., Bradley, W. G., & Moraes, C. T. (2006) · Molecular Neurobiology · doi:10.1385/mn:33:2:113 · Cited by 64 · see citing works

A call for the creation of personalized medicine databases

Gurwitz, D., Lunshof, J. E., & Altman, R. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1931 · Cited by 63 · see citing works

Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges

O’Bryant, S. E., Lista, S., Rissman, R. A., Edwards, M., Zhang, F., Hall, J. R., Zetterberg, H., Lovestone, S., Gupta, V. B., Graff‐Radford, N. R., et al. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.12.003 · Cited by 63 · see citing works

Artificial intelligence from A to Z: From neural network to legal framework

van Assen, M., Lee, S., & Cecco, C. N. D. (2020) · European Journal of Radiology · doi:10.1016/j.ejrad.2020.109083 · Cited by 62 · see citing works

Advances and perspectives from genetic research: development of biological markers in Alzheimer’s disease

Zetzsche, T., Rujescu, D., Hardy, J., & Hampel, H. J. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.48 · Cited by 61 · see citing works

Presenilin 2 Is the Predominant γ-Secretase in Microglia and Modulates Cytokine Release

Jayadev, S., Case, A., Eastman, A. J., Nguyen, H., Pollak, J., Wiley, J. C., Möller, T., Morrison, R. S., & Garden, G. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015743 · Cited by 60 · see citing works

Presenilin 2 influences miR146 level and activity in microglia

Jayadev, S., Case, A., Alajajian, B., Eastman, A. J., Möller, T., & Garden, G. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12400 · Cited by 60 · see citing works

Precision medicine in multiple sclerosis

Comabella, M., Sastre‐Garriga, J., & Montalbán, X. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000336 · Cited by 60 · see citing works

Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden — Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials

Isaac, M., Vamvakas, S., Abadie, E., Jönsson, B., Wied, C. C. G., & Pani, L. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.003 · Cited by 58 · see citing works

Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers

Hambly, N., Shimbori, C., & Kolb, M. R. J. (2015) · Respirology · doi:10.1111/resp.12569 · Cited by 55 · see citing works

Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer’s disease

Ohm, D. T., Fought, A. J., Martersteck, A., Coventry, C., Sridhar, J., Gefen, T. D., Weıntraub, S., Bigio, E. H., Mesulam, M. M., Rogalski, E. J., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12902 · Cited by 55 · see citing works

Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants

Blauwendraat, C., Wilke, C., Jansen, I. E., Schulte, C., Simón‐Sánchez, J., Metzger, F. G., Bender, B., Gasser, T., Maetzler, W., Rizzu, P., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.09.016 · Cited by 51 · see citing works

Cell-type-specific expression quantitative trait loci associated with Alzheimer disease in blood and brain tissue

Patel, D., Zhang, X., Farrell, J. J., Chung, J., Stein, T. D., Lunetta, K. L., & Farrer, L. A. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01373-z · Cited by 49 · see citing works

Companion diagnostics: the key to personalized medicine

Jørgensen, J. T. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1002470 · Cited by 48 · see citing works

The Link Between C-Reactive Protein and Alzheimer's Disease Among Mexican Americans

O'Bryant, S. E., for the Texas Alzheimer's Research & Care Consortium, Johnson, L., Edwards, M., Soares, H., Devous, M. D., Ross, S., Rohlfing, G., & Hall, J. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122071 · Cited by 47 · see citing works

Biomarkers of Parkinson's disease and Dementia with Lewy bodies

Henchcliffe, C., Dodel, R. C., & Beal, M. F. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.002 · Cited by 42 · see citing works

A haplotype of the methylenetetrahydrofolate reductase gene is protective against late-onset Alzheimer’s disease

Wakutani, Y., Kowa, H., Kusumi, M., Nakaso, K., Yasui, K., Isoe‐Wada, K., Yano, H., Urakami, K., Takeshima, T., & Nakashima, K. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00082-4 · Cited by 40 · see citing works

Prediction of conversion to dementia using interpretable machine learning in patients with amnestic mild cognitive impairment

Chun, M.-Y., Park, C. J., Kim, J.-H., Jeong, J., Jang, H., Kim, K., & Seo, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.898940 · Cited by 39 · see citing works

Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer's disease

Mansouri, L., Fekih‐Mrissa, N., Klai, S., Mansour, M., Gritli, N., & Mrissa, R. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.03.015 · Cited by 38 · see citing works

From inherited to sporadic AD—crossing the biomarker bridge

Hampel, H. J., & Lista, S. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.202 · Cited by 38 · see citing works

Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer’s Disease

Lista, S., Khachaturian, Z. S., Rujescu, D., Garaci, F., Dubois, B., & Hampel, H. J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_2 · Cited by 38 · see citing works

Advances in dementia with Lewy bodies

Armstrong, M. J. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211057666 · Cited by 37 · see citing works

Methyltetrahydrofolate vs Folic Acid Supplementation in Idiopathic Recurrent Miscarriage with Respect to Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms: A Randomized Controlled Trial

Hekmatdoost, A., Vahid, F., Yari, Z., Sadeghi, M. R., Eini‐Zinab, H., Lakpour, N., & Arefi, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143569 · Cited by 34 · see citing works

Next-generation diagnostics for precision oncology: Preanalytical considerations, technical challenges, and available technologies

Walter, W., Pfarr, N., Meggendorfer, M., Jost, P. J., Haferlach, T., & Weichert, W. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.015 · Cited by 34 · see citing works

Precision Medicine for Alzheimer’s Disease Prevention

Berkowitz, C. L., Mosconi, L., Scheyer, O., Rahman, A., Hristov, H., & Isaacson, R. (2018) · Healthcare · doi:10.3390/healthcare6030082 · Cited by 31 · see citing works

Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement

Hampel, H. J., & Lista, S. (2013) · The journal of nutrition health & aging · doi:10.1007/s12603-013-0003-1 · Cited by 29 · see citing works

Repeated systemic inflammation was associated with cognitive deficits in older Britons

Tampubolon, G. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.11.009 · Cited by 29 · see citing works

Biomarkers in Alzheimer’s disease

Janeiro, M. H., Ardanaz, C. G., Sola-Sevilla, N., Dong, J., Cortés-Erice, M., Solas, M., Puerta, E., & Ramírez, M. J. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0090 · Cited by 29 · see citing works

Statistical Consideration and Challenges in Bridging Study of Personalized Medicine

Li, M. (2014) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2014.920340 · Cited by 28 · see citing works

Society and ethics – the genetics of disease

Thomas, S. M. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.04.014 · Cited by 26 · see citing works

Biomarkers for Allergen Immunotherapy

Moingeon, P. E. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.08.004 · Cited by 26 · see citing works

Age-related neuropsychiatric symptoms in presenilins conditional double knockout mice

Li, Y., Li, L., Han, W., Pan, B., Xue, X., & Mei, B. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.06.002 · Cited by 24 · see citing works

MTHFR Gene Mutations: A Potential Marker of Late-Onset Alzheimer’s Disease?

Román, G. C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150304 · Cited by 24 · see citing works

A Review of the Familial Alzheimer’s Disease Locus PRESENILIN 2 and Its Relationship to PRESENILIN 1

Jiang, H., Jayadev, S., Lardelli, M. T., & Newman, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180656 · Cited by 24 · see citing works

The collective nature of personalized medicine

McGonigle, I. (2016) · Genetics Research · doi:10.1017/s0016672315000270 · Cited by 23 · see citing works

Thought Leader Perspectives on Participant Protections in Precision Medicine Research

Hammack, C. M., Brelsford, K. M., & Beskow, L. M. (2019) · Journal of Law, Medicine &amp; Ethics · doi:10.1177/1073110519840493 · Cited by 21 · see citing works

Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients

Currie, G. E., & Delles, C. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0661-6 · Cited by 19 · see citing works

New Perspectives for the Diagnosis of Alzheimers Disease

Urbanelli, L., Magini, A., Ciccarone, V. A., Trivelli, F., Polidoro, M., Tancini, B., & Emiliani, C. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909789104839 · Cited by 17 · see citing works

The impact of companion diagnostic device measurement performance on clinical validation of personalized medicine

Li, M., Yu, T., & Hu, Y. (2015) · Statistics in Medicine · doi:10.1002/sim.6476 · Cited by 17 · see citing works

C677T (RS1801133 ) MTHFR gene polymorphism frequency in a colombian population.

Romero‐Sánchez, C., Gómez, A., Gómez, P. E., Casas-Gómez, M. C., & Briceño, I. (2015) · Europe PMC (PubMed Central) · Cited by 16 · see citing works

Frecuencia del polimorfismo c677t (rs1801133) del gen MTFHR en individuos colombianos

Sánchez, C. R., Gómez, A., Gómez, P. E., Casas-Gómez, M. C., & Briceño, I. (2015) · Colombia medica · doi:10.25100/cm.v46i2.1607 · Cited by 16 · see citing works

Dementia Research and Care

OECD (2015) · OECD eBooks · doi:10.1787/9789264228429-en · Cited by 14 · see citing works

Corticosteroids in the treatment of community-acquired pneumonia: an evidence summary

Siemieniuk, R. A. C., & Guyatt, G. H. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2971 · Cited by 7 · see citing works

Biomarkers in Alzheimer’s disease

da Costa, L. M. D. P. R., Torres, G. D. S., Madruga, K. A. S., & dos Santos, P. R. (2021) · doi:10.5327/1516-3180.670 · Cited by 7 · see citing works

Precision medical communication to optimize stakeholder information exchange: a ‘4M-Quadrant’ approach

Ashkenazy, R. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.03.011 · Cited by 6 · see citing works

Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial

Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5 · see citing works

Mutations in the X-linked pyruvate dehydrogenase (E1) α subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency

Lissens, W., Meırleır, L. D., Seneca, S., Liebaers, I., Brown, G. K., Brown, R. M., Ito, M., Naito, E., Kuroda, Y., Kerr, D. S., et al. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200003)15:3 · Cited by 5 · see citing works

Prioritizing personalized medicine

Shomron, N. (2014) · Genetics Research · doi:10.1017/s0016672314000123 · Cited by 5 · see citing works

Untitled work

Waldvogel (1999) · doi:10.1002/1531-8249(199907)46:1

From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine

Toader, C., Șerban, M., Munteanu, O., Covache-Busuioc, R.-A., Enyedi, M., Ciurea, A. V., & Tătaru, C. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094271 · Cited by 152 · see citing works

Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer’s Disease Therapeutics

Dias, D., & Socodato, R. (2025) · Biomedicines · doi:10.3390/biomedicines13020279 · Cited by 57 · see citing works

Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease

Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2024) · Molecules · doi:10.3390/molecules29215131 · Cited by 56 · see citing works

Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches

Gholami, A. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137532 · Cited by 51 · see citing works

Resveratrol as a Therapeutic Agent in Alzheimer’s Disease: Evidence from Clinical Studies

Puranik, N., Kumari, M., Tiwari, S., Dhakal, T., & Song, M. (2025) · Nutrients · doi:10.3390/nu17152557 · Cited by 47 · see citing works

The role of machine learning in discovering biomarkers and predicting treatment strategies for neurodegenerative diseases: A narrative review

Aborode, A. T., Emmanuel, O. A., Onifade, I. A., Olotu, E., Otorkpa, O. J., Mehmood, M. Q., Abdulai, S. I., Jamiu, A. T., Osinuga, A., Oko, C. I., et al. (2025) · NeuroMarkers. · doi:10.1016/j.neumar.2024.100034 · Cited by 37 · see citing works

Could a Mediterranean Diet Modulate Alzheimer’s Disease Progression? The Role of Gut Microbiota and Metabolite Signatures in Neurodegeneration

Mafe, A. N., & Büsselberg, D. (2025) · Foods · doi:10.3390/foods14091559 · Cited by 35 · see citing works

A Transfer Learning Approach: Early Prediction of Alzheimer’s Disease on US Healthy Aging Dataset

Reddy, C. K. K., Rangarajan, A., Rangarajan, D., Shuaib, M., Jeribi, F., & Alam, S. (2024) · Mathematics · doi:10.3390/math12142204 · Cited by 36 · see citing works

Recent Insights into the Neurobiology of Alzheimer’s Disease and Advanced Treatment Strategies

Anitha, K., Singh, M. K., Kohat, K., Varshini, T. S., Chenchula, S., Padmavathi, R., Amerneni, L. S., Vishnu Vardhan, K., Mythili Bai, K., Chavan, M. R., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04384-1 · Cited by 32 · see citing works

The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer’s, and Parkinson’s disease’

Cantero‐Fortiz, Y., & Boada, M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1439125 · Cited by 32 · see citing works

Exploring sex differences in Alzheimer’s disease: a comprehensive analysis of a large patient cohort from a memory unit

Rosende‐Roca, M., García‐Gutiérrez, F., Cantero‐Fortiz, Y., Alegret, M., Pytel, V., Cañabate, P., González‐Pérez, A., de Rojas, I., Vargas, L., Tartari, J. P., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01656-9 · Cited by 30 · see citing works

Microglial dysfunction in Alzheimer's disease: Mechanisms, emerging therapies, and future directions

Azmal, M., Paul, J. K., Prima, F. S., Haque, A. N. M. S. N. B., Meem, M., & Ghosh, A. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115374 · Cited by 28 · see citing works

MicroRNA (miRNA) Complexity in Alzheimer’s Disease (AD)

Lukiw, W. J. (2023) · Biology · doi:10.3390/biology12060788 · Cited by 28 · see citing works

A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides

Singh, K., Gupta, J. K., Kumar, S., & Soni, U. (2024) · Current Protein and Peptide Science · doi:10.2174/0113892037275221240327042353 · Cited by 30 · see citing works

A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease

Devi, G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1213968 · Cited by 29 · see citing works

Advances in Alzheimer's therapy: Exploring neuropathological mechanisms to revolutionize the future therapeutic landscape

Sugandhi, V. V., Gadhave, D. G., Ugale, A. R., Kulkarni, N. N., Nangare, S., Patil, H. P., Rath, S., Saxena, R., Lavate, A., Patel, A. T., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102775 · Cited by 31 · see citing works

Genetic and epigenetic targets of natural dietary compounds as anti-Alzheimer’s agents

Ordoñez, W. O. C., Cajas‐Salazar, N., & Velasco-Reyes, M. A. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382232 · Cited by 26 · see citing works

Molecular Mechanisms Linking Osteoarthritis and Alzheimer’s Disease: Shared Pathways, Mechanisms and Breakthrough Prospects

Umoh, I. O., Reis, H. J., & de Oliveira, A. C. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25053044 · Cited by 26 · see citing works

Epigenetic biomarkers in Alzheimer's disease: Diagnostic and prognostic relevance

Behl, T., Kyada, A., Roopashree, R., Nathiya, D., Arya, R., Kumar, M., Khalid, M., Gulati, M., Sachdeva, M., Fareed, M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102556 · Cited by 25 · see citing works

The Major Hypotheses of Alzheimer’s Disease: Related Nanotechnology-Based Approaches for Its Diagnosis and Treatment

Cáceres, C., Heusser, B., Garnham, A., & Moczko, E. (2023) · Cells · doi:10.3390/cells12232669 · Cited by 24 · see citing works

Targeting NLRP3 inflammasome with curcumin: mechanisms and therapeutic promise in chronic inflammation

Pandey, S. N., Babu, M. A., Goyal, K., Menon, S. V., Ray, S., Kaur, M., Sharma, S., Rana, M., Rekha, A., Ali, H., et al. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01926-4 · Cited by 21 · see citing works

Chemistry, Biological Activities, and Pharmacological Properties of Gastrodin: Mechanism Insights

Menyiy, N. E., Elouafy, Y., Moubachir, R., Abdnim, R., Benali, T., Taha, D., Khalid, A., Abdalla, A. N., Hamza, S. M. A., Ibrahim, S. E., et al. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202400402 · Cited by 17 · see citing works

Unraveling the Complexity of Alzheimer’s Disease: Insights into Etiology and Advancements in Treatment Strategies

Khan, B., Iqbal, M. K., Khan, M. A., Khan, H. R., Kiyani, M. M., Bashir, S., & Li, S. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02337-4 · Cited by 17 · see citing works

Targeting inflammation and gut microbiota with antibacterial therapy: implications for central nervous system health

Wei, J., Liu, C., Qin, D., Ren, F., Duan, J., Chen, T., & Wu, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102544 · Cited by 15 · see citing works

Clinical prediction models using artificial intelligence approaches in dementia

Veronese, N., Bolzetta, F., Gallo, L., Durante, G., Vernuccio, L., Saccaro, C., Gambino, C. M., Custodero, C., Portincasa, P., Morotti, A., et al. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03112-6 · Cited by 15 · see citing works

Move to Remember: The Role of Physical Activity and Exercise in Preserving and Enhancing Cognitive Function in Aging—A Narrative Review

Martín-Rodríguez, A., Dalamitros, A. A., Madrigal-Cerezo, R., Sánchez-Conde, P., Clemente‐Suárez, V. J., & Tornero-Aguilera, J. F. (2025) · Geriatrics · doi:10.3390/geriatrics10060143 · Cited by 16 · see citing works

Genomic Insights into Dementia: Precision Medicine and the Impact of Gene-Environment Interaction

Tripathi, A., Pandey, V. K., Sharma, G., Sharma, A. R., Taufeeq, A., Jha, A. K., & Kim, J. (2024) · Aging and Disease · doi:10.14336/ad.2024.0322 · Cited by 13 · see citing works

FBXL16: a new regulator of neuroinflammation and cognition in Alzheimer’s disease through the ubiquitination-dependent degradation of amyloid precursor protein

Qu, L.-Q., Tang, Y., Wu, J.-H., Yun, X.-Y., Lo, H.-H., Song, L.-L., Wang, X.-X., Wang, H.-M., Zhang, R.-L., Liu, M.-H., et al. (2024) · Biomarker Research · doi:10.1186/s40364-024-00691-w · Cited by 10 · see citing works

The Benefits of Artificial Intelligence in Radiology: Transforming Healthcare through Enhanced Diagnostics and Workflow Efficiency

Bejarano, A. (2023) · The Review of Contemporary Scientific and Academic Studies · doi:10.55454/rcsas.3.08.2023.005 · Cited by 12 · see citing works

A Comprehensive Review of Modifiable Cardiovascular Risk Factors and Genetic Influences in Dementia Prevention

Khan, M. B., Jaiswal, A., & Wandile, B. V. (2023) · Cureus · doi:10.7759/cureus.48430 · Cited by 11 · see citing works

Exploratory Tau PET/CT with [11C]PBB3 in Patients with Suspected Alzheimer’s Disease and Frontotemporal Lobar Degeneration: A Pilot Study on Correlation with PET Imaging and Cerebrospinal Fluid Biomarkers

Strobel, J., Yousefzadeh‐Nowshahr, E., Deininger, K., Bohn, K. P., Arnim, C. A. F. V., Otto, M., Solbach, C., Anderl‐Straub, S., Polivka, D., Fissler, P., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071460 · Cited by 11 · see citing works

Development of a robust parallel and multi-composite machine learning model for improved diagnosis of Alzheimer's disease: correlation with dementia-associated drug usage and AT(N) protein biomarkers

Khan, A., Zubair, S., Shuaib, M., Sheneamer, A. M., Alam, S., & Assiri, B. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1391465 · Cited by 12 · see citing works

Dietary supplementation and the role of phytochemicals against the Alzheimer's disease: Focus on polyphenolic compounds

Naik, R. A., Rajpoot, R., Koiri, R. K., Bhardwaj, R., Aldairi, A. F., Johargy, A. K., Faidah, H. S., Babalghith, A. O., Hjazi, A. M., Alsanie, W. F., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100004 · Cited by 11 · see citing works

Predictive modeling of Alzheimer's disease progression: Integrating temporal clinical factors and outcomes in time series forecasting

Aqil, K. H., Dumpuri, P., Ram, K., & Sivaprakasam, M. (2024) · Intelligence-Based Medicine · doi:10.1016/j.ibmed.2024.100159 · Cited by 10 · see citing works

Promising Natural Remedies for Alzheimer’s Disease Therapy

Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2025) · Molecules · doi:10.3390/molecules30040922 · Cited by 13 · see citing works

Retinal Microstructural and Microvascular Changes in Alzheimer Disease: A Review

Ordoñez, M. A. O., Smith, R. C., Yiu, G. C., & Liu, Y. (2024) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000549 · Cited by 9 · see citing works

The Role of GFAP in Post-Mortem Analysis of Traumatic Brain Injury: A Systematic Review

Sacco, M. A., Gualtieri, S., Tarallo, A. P., Verrina, M. C., Calafiore, J., Princi, A., Lombardo, S., Ranno, F., Cello, A. D., Gratteri, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010185 · Cited by 9 · see citing works

Non-coding RNAs in the pathogenesis of Alzheimer’s disease: β-amyloid aggregation, Tau phosphorylation and neuroinflammation

Jiménez‐Ramírez, I. A., & Castaño, E. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10284-x · Cited by 11 · see citing works

Revolutionizing Alzheimer’s Detection: Immune-Related Gene Biomarkers as Non-Invasive Predictors

Abed, S., Ebrahimi, A., Fattahi, F., Khaniani, M. S., & Derakhshan, S. M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04970-x · Cited by 8 · see citing works

Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer’s disease

Kanda, A., Rani, A., & Mazumder, A. (2025) · Pharmacogenomics · doi:10.1080/14622416.2025.2560296 · Cited by 8 · see citing works

Unveiling Role of Gut Microbiota in Alzheimer’s Disease: Mechanisms, Challenges and Future Perspectives

Radhakrishnan, P., Viswanathan, K., Sonali, L., Suneetha, C., & Muthusamy, S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050403066250904112611 · Cited by 12 · see citing works

Network Dynamics‐based Subtyping of Alzheimer's Disease With Microglial Genetic Risk Factors

Choi, J. H., Lee, J., Kang, U., Chang, H., & Cho, K.-H. (2024) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-024-01583-9 · Cited by 7 · see citing works

Phenotyping to predict 12-month health outcomes of older general medicine patients

Woodman, R. J., Bryant, K., Sorich, M. J., Thompson, C. H., Russell, P. T., Pilotto, A., & Mangoni, A. A. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-024-02924-2 · Cited by 7 · see citing works

Brain aging: Unlocking personalized strategies for cognitive resilience

Saliev, T. M. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2025.09.002 · Cited by 7 · see citing works

Emerging blood biomarkers in Alzheimer’s disease: a proteomic perspective

Patel, N. K., Agrawal, N., Mishra, R., Rekha, M. M., Nayak, P. P., Kaur, M., Khachi, A., Goyal, K., Rekha, A., Rana, M., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120397 · Cited by 6 · see citing works

Sex in the medical machine: How algorithms can entrench bioessentialism in precision medicine

Ichikawa, K., Boulicault, M., Thinius, A., DiMarco, M., Murchland, A. R., Maldonado, B., Higgins, A., & Richardson, S. S. (2025) · Big Data & Society · doi:10.1177/20539517251381674 · Cited by 6 · see citing works

The Future of Precision Medicine: Targeted Therapies, Personalized Medicine and Formulation Strategies

Rongala, G., Rongala, D. S., & Rongala, A. N. (2025) · Journal of Pharmaceutical and BioTech Industry · doi:10.3390/jpbi2040019 · Cited by 6 · see citing works

Personalized Medicine Approach to Proteomics and Metabolomics of Cytochrome P450 Enzymes: A Narrative Review

Fetse, J., Olawode, E. O., & Deb, S. (2024) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-024-00912-5 · Cited by 6 · see citing works

Up-regulation of myelin-associated glycoprotein is associated with the ameliorating effect of omega-3 polyunsaturated fatty acids on Alzheimer's disease progression in APP–PS1 transgenic mice

Shao, Y. H., Li, F., Zou, B., Jin, Y., Wang, X., Wang, L.-T., Huang, Y., Xie, Y., Sun, W., Kang, J. X., et al. (2024) · Food & Function · doi:10.1039/d4fo03355h · Cited by 6 · see citing works

A real-world safety surveillance study of aducanumab through the FDA adverse event reporting system

Huang, J., Long, X., & Chen, C. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1522058 · Cited by 6 · see citing works

Infections, genetics, and Alzheimer's disease: Exploring the pathogenic factors for innovative therapies

Kordi, R., Andrews, T. J., & Hicar, M. D. (2025) · Virology · doi:10.1016/j.virol.2025.110523 · Cited by 6 · see citing works

Artificial Intelligence Opportunities to Guide Precision Dosing Strategies

Barrett, J. S. (2024) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-29.4.434 · Cited by 6 · see citing works

Considerations for informing precision psychiatry in eating disorders: Foundations for future practice

Obeid, N., Lavallée, N., Bradley, A. H. M., & Norris, M. L. (2025) · Journal of Eating Disorders · doi:10.1186/s40337-025-01351-6 · Cited by 5 · see citing works

Alzheimer’s 2030: From Precision Genomics to Artificial Intelligence

D’Argenio, V., Tomaiuolo, R., Bargeri, S., & Sancesario, G. M. (2026) · Genes · doi:10.3390/genes17020233 · Cited by 5 · see citing works

More than a number: Incorporating the aged phenotype to improve in vitro and in vivo modeling of neurodegenerative disease

Carr, L. M., Mustafa, S., Care, A., & Collins‐Praino, L. E. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.023 · Cited by 5 · see citing works

Polymerase Chain Reaction Chips for Biomarker Discovery and Validation in Drug Development

Vo, D.-K., & Trinh, K. T. L. (2025) · Micromachines · doi:10.3390/mi16030243 · Cited by 5 · see citing works

Genetic and epigenetic drivers of neurodegenerative disorders

Roy, K., Syed, M., Narad, P., & Sengupta, A. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.08.002 · Cited by 5 · see citing works

Alzheimer’s Disease: A Suitable Case for Treatment with Precision Medicine?

Pauwels, E. K. J., & Boer, G. J. (2024) · Medical Principles and Practice · doi:10.1159/000538251 · Cited by 4 · see citing works

Integrating molecular imaging with near-infrared theranostics to improve early detection and therapy of Alzheimer's disease

Mahajan, G., Pandya, K., Tripathi, A., & Kumar, D. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108949 · Cited by 3 · see citing works

Unconventional Non-rodent Models in Neurological Research: Exploring New Paths to Translational Insights

Devi, A., Saini, C. S., Shiven, A., Kumar, A., Sharma, A., Joshi, N., Kour, S., Khan, Z. A., Dewangan, H. K., & Dwibedi, V. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02408-6 · Cited by 3 · see citing works

EVs from Stem Cells Improve Mitochondrial Dysfunction in Neuronal Disorders

Jahan, S., Kumar, D., Ali, S., Siddiqui, A. J., Alaidarous, M., Khan, J., & Khan, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05623-9 · Cited by 3 · see citing works

Bridging the gaps in alzheimer’s disease: a comprehensive review of current and emerging therapies

Mostafa, R. E., & Asaad, G. F. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02151-3 · Cited by 4 · see citing works

From Molecular Networks to Medicines: Targeting Complexity in Alzheimer’s Disease (AD) Therapy

Kumar, D. R. P., Patel, S., Mishra, P. S., Srivastava, S., Sridhar, S. B., Shareef, J., Sahu, R., Tariq, M., Uddin, J., & Muhsinah, A. B. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05909-6 · Cited by 3 · see citing works

Current and emerging therapeutic approaches in Alzheimer’s disease

Chauhan, A., Devi, R., Singh, S., Thakur, R., Bhutani, K., Sharma, R., Kumari, A., Kumar, H., Pal, S., & Saini, A. K. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00290-5 · Cited by 3 · see citing works

Unravelling AI and Machine Learning Essentials in Alzheimer's Research

Saravanan, V., Kalangi, R. R., Thangavel, S., & Venkata Ramana, K. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-3605-2.ch010 · Cited by 3 · see citing works

A novel Alzheimer detection rapid-testing low-cost technique by a gate engineered gate stack dual-gate FET device

Kolay, A., & Kumar, A. (2024) · Talanta · doi:10.1016/j.talanta.2024.127438 · Cited by 3 · see citing works

Proposed Therapeutic Strategy to Combat Alzheimer’s Disease by Targeting Beta and Gamma Secretases

Kumar, D., Anand, P., & Singh, S. K. (2025) · Current Alzheimer Research · doi:10.2174/0115672050380899250602042028 · Cited by 3 · see citing works

Developing and applying potentially scalable recruitment strategies to accelerate ADRD research participation of Black adults

Richards, R., Richards, M., Musema, J., Tackett, A., Heiden, S. V., Polsinelli, A. J., Gao, S., Brown, S. A., Unverzagt, F. W., Risacher, S. L., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14440 · Cited by 3 · see citing works

Future directions for neurodegenerative disease management

Panambur, S., Thomas, P. M., Sridhar, S. B., & Chalasani, S. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00024-6 · Cited by 2 · see citing works

Mild Cognitive Impairment Detection through Gait Analysis and Standard Cameras

Farrell, B., Horn, J., Seifallahi, M., Galvin, J. E., & Ghoraani, B. (2024) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc53108.2024.10782745 · Cited by 2 · see citing works

Weight trajectories in aging humanized APOE mice with translational validity to human Alzheimer’s risk population: A retrospective analysis

Vitali, F., Wiegand, J. L., Parker-Halstead, L., Tucker, A., & Brinton, R. D. (2025) · PLoS ONE · doi:10.1371/journal.pone.0314097 · Cited by 2 · see citing works

Exploring interdisciplinary perspectives on the implementation of personalized medicine and patient-orchestrated care in Alzheimer's disease: A qualitative study within the ABOARD research project

de Rijke, T. D., Vasseur, D., van der Flier, W. M., Minkman, M., Rhodius-Meester, H., Verwey, N., Smets, E., & Visser, L. (2025) · Journal of Alzheimer's Disease · doi:10.1177/13872877251326166 · Cited by 1 · see citing works

An experimental study of the dual modulation of the colchicine-induced rat model of Alzheimer’s disease by superparamagnetic iron oxide nanoparticles (SPIONs) and the soluble product of Dipylidium caninum adult worm

Elsharkawy, A. M., Hassanein, F., Abouelkheir, S. S., Masoud, I. M., Felefel, W., & Darwish, I. E. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324191 · Cited by 2 · see citing works

Precision therapeutics for Alzheimer’s disease

Priyanka, S., Manjari, T., Hemalatha, S., Ambika, S., Yilmaz, B. N., Aktürk, B., Arısan, E. D., Kumari, A., & Manojkumar, Y. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.08.011 · Cited by 2 · see citing works

Advances in artificial intelligence-based radiogenomics for lung cancer precision medicine

Sun, Y., Guo, X., Liu, X., Liu, H., & Wang, X. (2025) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ae224a · Cited by 2 · see citing works

Targeting Neuroinflammation in Synaptic Dysfunction: Translational Pharmacology for Neurodegenerative and Neuropsychiatric Disorders

Bhatia, N., Khan, M. M. U., Masih, D., & Srinivas, U. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00318-w · Cited by 2 · see citing works

The potential of artificial intelligence in advancing neuroscience: A systematic review of current applications and models

Afroughi, F., SeyedAlinaghi, S., Mirzapour, P., Shirdel, S., Parmoon, Z., Khorshidi, M. M., Mansouri, S., Sheykhi, M., Popoola, Y., & Mehraeen, E. (2025) · Intelligence-Based Medicine · doi:10.1016/j.ibmed.2025.100338 · Cited by 3 · see citing works

Real-World Impact

Muppavaram, K., Gangopadhyay, A., Ramadass, S., Prakash, N., & Siva Shankar, S. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-3605-2.ch016 · Cited by 2 · see citing works

Integrating genomics and neuroimaging for improved brain disease diagnosis

Viswanathan, A., Brahma, N., & Vimal, S. (2024) · Neurosurgical Review · doi:10.1007/s10143-024-02747-9 · Cited by 2 · see citing works

Therapeutic Potential of Ramalin Derivatives with Enhanced Stability in the Treatment of Alzheimer’s Disease

Kim, T. K., Hong, J., Kim, J., Kim, K. H., Han, S. J., Kim, I., Oh, H., Jo, D., & Yim, J. H. (2024) · Molecules · doi:10.3390/molecules29225223 · Cited by 2 · see citing works

The role of fusion proteins as biomarkers and therapeutic agents for Alzheimer's disease: A narrative review

Agustini, D., Sabloak, R., Hasan, S., & Umar, T. P. (2025) · NeuroMarkers. · doi:10.1016/j.neumar.2025.100041 · Cited by 2 · see citing works

M3L: Multi-modal machine learning framework integrated with Nano-informatics for early prediction of Rheumatoid Arthritis

Ahmad, S., & Parveen, R. (2025) · EDPACS · doi:10.1080/07366981.2025.2518666 · Cited by 2 · see citing works

Therapeutic approaches in proteinopathies

Nabi‐Afjadi, M., Dabirmanesh, B., & Uversky, V. N. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.008 · Cited by 2 · see citing works

The genetic face of brain diseases

Shehryar, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00012-x · Cited by 1 · see citing works

Silencing NRBP1 Gene with shRNA Improves Cognitive Function and Pathological Features in AD Rat Model

Wei, X., Liu, X., Ban, Y., Li, J., & Rong, H. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11169-1 · Cited by 1 · see citing works

HY-021068 improves neuronal ferroptosis by activating Nrf2 signaling in APP/PS1 Mice and Aβ1-42-induced HT22 cells

Huang, Y., Han, M. H., Fu, Y., Wang, G., Kong, L., Mo, J., Cao, D., Chu, Z., & Li, W. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178349 · Cited by 2 · see citing works

Genetic and Epigenetic Modifications in Alzheimer’s Disease: Pathophysiology, Biomarkers, and Therapeutics – A Systematic Review

Gupta, D. K., & Chaudhuri, A. (2025) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_57_25 · Cited by 1 · see citing works

Enhancing Alzheimer’s Diagnosis Through Spontaneous Speech Recognition: Deep Learning Approach with Data Augmentation

Mutala, V. S. B., Pouriyeh, S., Xie, C. Y., Han, M., Basile, I., & Sannino, G. (2025) · IEEE Symposium on Computers and Communications (ISCC) · doi:10.1109/iscc65549.2025.11325956 · Cited by 1 · see citing works

Environmentally Driven Precision Neurology: A Neurogenomic Perspective

Ang, M. Y., Feisal, N. A. S., Ramli, M. D. C., & Hein, Z. M. (2026) · Biology · doi:10.3390/biology15030283 · Cited by 1 · see citing works

Unveiling unified patterns in Alzheimer’s disease subtypes: An SCCA clustering approach integrating PET imaging and genomics data

Yang, F., Maher, M., Saxena, R., & Dutta, J. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1151 · Cited by 1 · see citing works

Environmental toxins, PFAS exposure, and brain metabolism: A new angle in Alzheimer’s disease pathophysiology

Jain, V., & Bharti, S. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.01.011 · Cited by 1 · see citing works

Neuroprotective effects of ursodeoxycholic acid in Parkinson's disease and Alzheimer's disease

Chong, A. E. Y., Sasmita, A. O., Koh, R. Y., & Ling, A. P. K. (2026) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70039 · Cited by 1 · see citing works

Biomarkers of chemical- and drug-induced neurotoxicity: A review of mechanistic insights and neuroprotective strategies

Alshammari, A. A. A., & Mani, V. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116335 · Cited by 1 · see citing works

Bridging Health Disparity Gaps in Alzheimer’s Disease among Marginalized Populations: Clinical Proteomics as a Case Study

Adeola, H. A., & Robinson, R. A. S. (2025) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.5c00074 · Cited by 1 · see citing works

Leveraging Existing Abilities in Dementia (LEAD™): Changing the Way Rehabilitation Professionals Care for Persons Living with Dementia

Dawson, N. T., Trapuzzano, A., & Judge, K. S. (2024) · OBM Geriatrics · doi:10.21926/obm.geriatr.2402275

Early-Onset Alzheimer’s Disease, APOE4 And C9orf72 Expansion: A Case Report

Enrique-Benedito, T., Senoret, V., Sanchis, M., Penacho, V., Caracuel, Z., Arrizabalaga, M., Campoy, M. B., & Alcaraz, L. A. (2024) · Annals of Case Reports · doi:10.29011/2574-7754.101812

The Precision Medicine: Advancement and Transformation in Cancer TreatmentPreprint

Khobragade, S., VYAS, U. B., Pethe, A. M., & Ingle, R. G. (2024) · Preprints.org · doi:10.20944/preprints202406.2018.v1

ASPECTOS CLÍNICOS E TERAPÊUTICOS DA OSTEONECROSE DA MANDÍBULA: IMPLICAÇÕES PARA A PRÁTICA ODONTOLÓGICA

Paiva, A. C., Moretti, J. C. G. A., Beneti, I. M., & Kassis, E. N. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n7-014

Unravelling Alzheimer's

Suja, G. P. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-3605-2.ch012

Unravelling Data Challenges in AI-Driven Alzheimer's Research

Arunadevi, B., Dakshinamurthi, V., Fernandes, B., & Sharmiladevi, D. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-3605-2.ch014

A Precision Medicine Initiative for Alzheimer’s disease: the road ahead to biomarker-guided integrative disease modeling

Hampel, H., O’Bryant, S. E., Durrleman, S., Younesi, E., Rojkova, K., Escott-Price, V., Corvol, J.-C., Broich, K., Dubois, B., Lista, S., et al. (2017) · Climacteric · doi:10.1080/13697137.2017.1287866 · Cited by 147 · see citing works

PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE

Hampel, H. J., O’Bryant, S. E., Castrillo, J. I., Ritchie, C. W., Rojkova, K., Broich, K., Benda, N., Nisticò, R., Frank, R., Dubois, B., et al. (2016) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2016.112 · Cited by 116 · see citing works

The road to precision medicine: Eliminating the “One Size Fits All” approach in Alzheimer’s disease

Behl, T., Kaur, I., Sehgal, A., Singh, S., Albarrati, A., Albratty, M., Najmi, A., Meraya, A. M., & BUNGAU, S. G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113337 · Cited by 64 · see citing works

Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer’s disease

Kanda, A., Rani, A., & Mazumder, A. (2025) · Pharmacogenomics · doi:10.1080/14622416.2025.2560296 · Cited by 8 · see citing works

Alzheimer’s disease: From basic science to precision medicine approach

Forloni, G. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2020-000079 · Cited by 33 · see citing works